110 related articles for article (PubMed ID: 33430962)
1. MicroRNA-320a: an important regulator in the fibrotic process in interstitial lung disease of systemic sclerosis.
Li Y; Huang J; Hu C; Zhou J; Xu D; Hou Y; Wu C; Zhao J; Li M; Zeng X; Liu C; Wang Q; Zhao Y
Arthritis Res Ther; 2021 Jan; 23(1):21. PubMed ID: 33430962
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of plasma exosomal miR-34-5p and miR-142-3p in systemic sclerosis].
Li WG; Gu XD; Weng RQ; Liu SD; Chen C
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1022-1027. PubMed ID: 38101783
[TBL] [Abstract][Full Text] [Related]
3. MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.
Shi X; Liu Q; Li N; Tu W; Luo R; Mei X; Ma Y; Xu W; Chu H; Jiang S; Du Z; Zhao H; Zhao L; Jin L; Wu W; Wang J
Cell Cycle; 2018; 17(16):1967-1978. PubMed ID: 30145936
[TBL] [Abstract][Full Text] [Related]
4. Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease.
Soldano S; Smith V; Montagna P; Gotelli E; Campitiello R; Pizzorni C; Paolino S; Sulli A; Cere A; Cutolo M
Arthritis Res Ther; 2024 Mar; 26(1):74. PubMed ID: 38509595
[TBL] [Abstract][Full Text] [Related]
5. Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma-Associated Lung Fibrosis.
Bogatkevich GS; Atanelishvili I; Bogatkevich AM; Silver RM
Arthritis Rheumatol; 2023 Mar; 75(3):438-448. PubMed ID: 36103378
[TBL] [Abstract][Full Text] [Related]
6. High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies.
Al-Adwi Y; Atzeni IM; Doornbos-van der Meer B; van der Leij MJ; Varkevisser RDM; Kroesen BJ; Stel A; Timens W; Gan CT; van Goor H; Westra J; Mulder DJ
EBioMedicine; 2023 Dec; 98():104883. PubMed ID: 37995465
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis-Associated Interstitial Lung Disease.
Papazoglou A; Huang M; Bulik M; Lafyatis A; Tabib T; Morse C; Sembrat J; Rojas M; Valenzi E; Lafyatis R
Arthritis Rheumatol; 2022 Dec; 74(12):2003-2014. PubMed ID: 35849803
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of TNF-induced protein 3 and CCAAT/enhancer-binding protein β in alveolar macrophages: Implications for systemic sclerosis-associated interstitial lung disease.
Hua X; Hongbing R; Juan X; Jizan L; Beibei Y
Int J Rheum Dis; 2024 May; 27(5):e15174. PubMed ID: 38720423
[TBL] [Abstract][Full Text] [Related]
9. Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease.
Yang MM; Lee S; Neely J; Hinchcliff M; Wolters PJ; Sirota M
Front Immunol; 2024; 15():1326922. PubMed ID: 38348044
[TBL] [Abstract][Full Text] [Related]
10. Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.
Morozan A; Joy S; Fujii U; Fraser R; Watters K; Martin JG; Colmegna I
Sci Rep; 2023 Nov; 13(1):20577. PubMed ID: 37996447
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide DNA methylation and transcriptome expression profiles of peripheral blood mononuclear cells in patients with systemic sclerosis with interstitial lung disease.
Xie Y; Zhao H; Luo H; Zuo X; Li Q; Liu S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 48(6):829-836. PubMed ID: 37587067
[TBL] [Abstract][Full Text] [Related]
12. NADPH-derived ROS generation drives fibrosis and endothelial-to-mesenchymal transition in systemic sclerosis: Potential cross talk with circulating miRNAs.
Posadino AM; Erre GL; Cossu A; Emanueli C; Eid AH; Zinellu A; Pintus G; Giordo R
Biomol Concepts; 2022 Feb; 13(1):11-24. PubMed ID: 35189048
[TBL] [Abstract][Full Text] [Related]
13. Molecular Features and Stages of Pulmonary Fibrosis Driven by Type 2 Inflammation.
Mattoo H; Bangari DS; Cummings S; Humulock Z; Habiel D; Xu EY; Pate N; Resnick R; Savova V; Qian G; Beil C; Rao E; Nestle FO; Bryce PJ; Subramaniam A
Am J Respir Cell Mol Biol; 2023 Oct; 69(4):404-421. PubMed ID: 37369139
[TBL] [Abstract][Full Text] [Related]
14. Increased CD8+ tissue resident memory T cells, regulatory T cells and activated natural killer cells in systemic sclerosis lungs.
Padilla CM; Valenzi E; Tabib T; Nazari B; Sembrat J; Rojas M; Fuschiotti P; Lafyatis R
Rheumatology (Oxford); 2024 Mar; 63(3):837-845. PubMed ID: 37310903
[TBL] [Abstract][Full Text] [Related]
15. Gene Expression Meta-Analysis Reveals Aging and Cellular Senescence Signatures in Scleroderma-associated Interstitial Lung Disease.
Yang MM; Lee S; Neely J; Hinchcliff M; Wolters PJ; Sirota M
bioRxiv; 2023 Nov; ():. PubMed ID: 37986995
[TBL] [Abstract][Full Text] [Related]
16. Integrative genetic and genomic networks identify microRNA associated with COPD and ILD.
Pavel AB; Garrison C; Luo L; Liu G; Taub D; Xiao J; Juan-Guardela B; Tedrow J; Alekseyev YO; Yang IV; Geraci MW; Sciurba F; Schwartz DA; Kaminski N; Beane J; Spira A; Lenburg ME; Campbell JD
Sci Rep; 2023 Aug; 13(1):13076. PubMed ID: 37567908
[TBL] [Abstract][Full Text] [Related]
17. CD4
Qin L; Lin H; Zhu F; Wang J; Feng T; Xu T; Zhang G; Zhang X
iScience; 2023 Dec; 26(12):108225. PubMed ID: 38025770
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of miR-320a in lung cancer: a comprehensive review.
Mohanta A; Kumar RR; Singh RK; Mandal S; Yadav R; Khatkar R; Sharma U; Uttam V; Rana MK; Rana AP; Jain A
Biomark Med; 2023 Sep; 17(18):767-781. PubMed ID: 38095986
[TBL] [Abstract][Full Text] [Related]
19. An interleukin 6 responsive plasma cell signature is associated with disease progression in systemic sclerosis interstitial lung disease.
Jia G; Ramalingam TR; Heiden JV; Gao X; DePianto D; Morshead KB; Modrusan Z; Ramamoorthi N; Wolters P; Lin C; Khanna D; Arron JR
iScience; 2023 Nov; 26(11):108133. PubMed ID: 37867940
[TBL] [Abstract][Full Text] [Related]
20. miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis.
Khedr AM; Shaker OG; El-Komy MH; Badr AM; Erfan R
Noncoding RNA Res; 2024 Mar; 9(1):253-261. PubMed ID: 38222070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
